Literature DB >> 2784966

Very late activation antigen on synovial fluid T cells from patients with rheumatoid arthritis and other rheumatic diseases.

A Laffon1, F Sánchez-Madrid, M Ortíz de Landázuri, A Jiménez Cuesta, A Ariza, C Ossorio, P Sabando.   

Abstract

We used flow cytometry and immunoprecipitation techniques to study the expression of the activation molecules transferrin receptor, interleukin-2 receptor, HLA-DR, and very late activation antigen 1 (VLA-1) on purified T lymphocytes from peripheral blood and synovial fluid of 9 patients with rheumatoid arthritis and 7 patients with other rheumatic diseases. We found a T cell subset bearing VLA-1 in synovial fluid from 8 rheumatoid arthritis patients and 4 patients with other rheumatic diseases. VLA-1 was not found in peripheral blood T lymphocytes from either group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784966     DOI: 10.1002/anr.1780320405

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Anti-integrin immunotherapy in rheumatoid arthritis: protective effect of anti-alpha 4 antibody in adjuvant arthritis.

Authors:  C Barbadillo; A G-Arroyo; C Salas; J Mulero; F Sánchez-Madrid; J L Andreu
Journal:  Springer Semin Immunopathol       Date:  1995

2.  Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups.

Authors:  F W Miller; L A Love; S A Barbieri; J E Balow; P H Plotz
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

3.  Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis.

Authors:  J M Van Laar; A M Miltenburg; M J Verdonk; M R Daha; R R De Vries; P J Van den Elsen; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

4.  Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis.

Authors:  A Afeltra; M Galeazzi; G M Ferri; A Amoroso; O De Pità; F Porzio; L Bonomo
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

5.  VLA family in rheumatoid arthritis: evidence for in vivo regulated adhesion of synovial fluid T cells to fibronectin through VLA-5 integrin.

Authors:  R García-Vicuña; A Humbría; A A Postigo; C López-Elzaurdia; M O de Landázuri; F Sánchez-Madrid; A Laffón
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

6.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Authors:  A A Postigo; R Garcia-Vicuña; F Diaz-Gonzalez; A G Arroyo; M O De Landázuri; G Chi-Rosso; R R Lobb; A Laffon; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Expression and functions of very late antigen 1 in inflammatory joint diseases.

Authors:  I Bank; D Roth; M Book; A Guterman; I Shnirrer; R Block; M Ehrenfeld; P Langevitz; H Brenner; M Pras
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

8.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

Authors:  A Laffón; R García-Vicuña; A Humbría; A A Postigo; A L Corbí; M O de Landázuri; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Interleukin-15 and interferon-gamma participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production.

Authors:  Isidoro González-Alvaro; Carmen Domínguez-Jiménez; Ana M Ortiz; Vanessa Núñez-González; Pedro Roda-Navarro; Elena Fernández-Ruiz; David Sancho; Francisco Sánchez-Madrid
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.